<h3>Gainers</h3>
<ul>
<li>Psyence Biomedical (NASDAQ:PBM) stock rose 77.2% to $10.4 during Friday's pre-market session. The company's market cap stands at $6.0 million. </li>
<li>iSpecimen (NASDAQ:ISPC) stock rose 34.76% to $0.16. The company's market cap stands at $3.4 million. </li>
<li>Corvus Pharmaceuticals (NASDAQ:CRVS) shares increased by 14.69% to $17.25. The company's market cap stands at $1.2 billion. </li>
<li>AN2 Therapeutics (NASDAQ:ANTX) shares increased by 14.33% to $3.59. The company's market cap stands at $112.8 million. </li>
<li>Kura Oncology (NASDAQ:KURA) shares rose 12.75% to $10.08. The company's market cap stands at $793.5 million. </li>
<li>Beyond Air (NASDAQ:XAIR) shares moved upwards by 12.33% to $0.5. The market value of their outstanding shares is at $4.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Enveric Biosciences (NASDAQ:ENVB) shares fell 16.2% to $1.97 during Friday's pre-market session. The company's market cap stands at $3.2 million. </li>
<li>Harvard Bioscience (NASDAQ:HBIO) stock fell 10.16% to $5.31. The market value of their outstanding shares is at $26.4 million. </li>
<li>Trevi Therapeutics (NASDAQ:TRVI) shares declined by 8.88% to $13.25. The company's market cap stands at $1.8 billion. </li>
<li>Actuate Therapeutics (NASDAQ:ACTU) shares fell 8.87% to $1.96. The market value of their outstanding shares is at $50.9 million. </li>
<li>Propanc Biopharma (NASDAQ:PPCB) shares decreased by 8.0% to $0.1. The company's market cap stands at $2.3 million. </li>
<li>Hoth Therapeutics (NASDAQ:HOTH) stock declined by 7.43% to $0.69. The company's market cap stands at $14.2 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TRVI

CRVS

ANTX

ISPC

In Friday's pre-market session, Psyence Biomedical (PBM) saw a significant gain of 77.2%, reaching $10.4, while iSpecimen (ISPC) rose 34.76% to $0.16. Other gainers included Corvus Pharmaceuticals (CRVS) up 14.69% to $17.25 and AN2 Therapeutics (ANTX) up 14.33% to $3.59. Conversely, Enveric Biosciences (ENVB) fell 16.2% to $1.97, and Harvard Bioscience (HBIO) dropped 10.16% to $5.31. Trevi Therapeutics (TRVI) declined 8.88% to $13.25, among others.

12 Health Care Stocks Moving In Friday's Pre-Market Session